Stock Events

Stock Events

AIxCrypto 

€0
29
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

8MayExpected
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Next
-23.94
-23.6
-23.27
-22.94
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-11.45MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7R90.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes in the development of therapeutics in areas similar to Qualigen, such as viral diseases, making it a direct competitor.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotech firm focusing on human therapeutics, including treatments for illnesses that Qualigen also targets, positioning it as a competitor.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb operates in the biopharmaceutical field, developing prescription drugs that overlap with Qualigen's therapeutic areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation with a broad product portfolio that includes treatments in areas competing with Qualigen's focus.
Merck
MRK
Mkt Cap214.76B
Merck & Co. is known for its innovative medicines and vaccines, some of which directly compete with Qualigen's product pipeline.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a research-based biopharmaceutical company with a strong emphasis on developing innovative therapies, including those in competition with Qualigen.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious conditions, competing with Qualigen's therapeutic areas.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is focused on creating new possibilities in medicine to cure diseases and improve people's lives, including areas where Qualigen operates.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including in sectors where Qualigen is active.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of medical therapies that compete with Qualigen's developments.

About

Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Show more...
CEO
Mr. Michael S. Poirier
Employees
4
Country
US
ISIN
US74754R3012
WKN
000A40THA

Listings

F
DE
7R90.F
XNAS
US
AIXC
BOATS
BOATS
AIXC.BOATS

0 Comments

Share your thoughts

FAQ

What is AIxCrypto stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange AIxCrypto stocks are traded under the ticker 7R90.F.
When is the next AIxCrypto earnings date?▼
AIxCrypto is going to release the next earnings report on May 08, 2026.
What is AIxCrypto revenue for the last year?▼
AIxCrypto revenue for the last year amounts to 0 EUR.
What is AIxCrypto net income for the last year?▼
7R90.F net income for the last year is -11.45M EUR.
How many employees does AIxCrypto have?▼
As of April 04, 2026, the company has 4 employees.
In which sector is AIxCrypto located?▼
AIxCrypto operates in the Healthcare sector.
When did AIxCrypto complete a stock split?▼
The last stock split for AIxCrypto was on November 05, 2024 with a ratio of 1:50.
Where is AIxCrypto headquartered?▼
AIxCrypto is headquartered in Carlsbad, US.